1. |
Daemen J, Kuek KH, Maeaya C, et al. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial. J Am Coll Cardiol, 2008, 52(24): 1957-1967.
|
2. |
Yang JH, Gwon HC, Cho SJ, et al. Comparison of coronary artery bypass grafting with drug-eluting stent implantation for the treatment of multivessel coronary artery disease. Ann Thorac Surg, 2008, 85(1): 65-70.
|
3. |
Tarantini G, Ramondo A, Napodano M. PCI versus CABG for multivessel coronary disease indiabetics. Catheter Cardiovasc Intery, 2009, 73(1): 50-58.
|
4. |
Qiao Y, Ma C, Nie S, et al. Twelve months clinical outcome of drug-eluting stents implantation or coronary artery bypass surgery for the treatment of diabetic patients with multivessel disease. Clin Cardiol, 2009, 32(8): E24-30.
|
5. |
Li Y, Zheng Z, Xu B, et al. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution. Circulation, 2009, 119(15): 2040-2050.
|
6. |
Kapur A, Bartolini D, Finlay MC, et al. The bypass angioplasty revascularization in type 1 and 2 diabetes study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease. J Cardiovasc Med, 2010, 11(1): 26-33.
|
7. |
Banning AP, Westabys, Morice MC, et al. Diabetic and nondiabetic Patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents. J Am Coll Cardiol, 2010, 55(11): 1067-1075.
|
8. |
Kapur A, Hall RJ, Malik IS, et al. Randomized comparison of percutaneous coronary Intervention with coronary artery bypass grafting in diabetic Patients: 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. J Am Coll Cardiol, 2010, 55(5): 432-440.
|
9. |
Uddin SN, Malik F, Bari MA, et al. Angiographic severity and extent of coronary artery disease in patients with type 2 diabetes mellitus. Mymensingh Med J, 2005, 14(1): 32-37.
|
10. |
Seheen AJ, warze’e F, Legrand VM. Drug-eluting stents: Meta-analysis in diabetic patients. Eur Heart J, 2004, 25: 2167-2168.
|
11. |
Banmgart D, Klauss V, Baer F, et al. One-year results of the SCORPIUS study: a German Multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patients. Joumal of the Ameriean College of Cardiology, 2007, 50: 1627-1634.
|
12. |
Tu JV, Bowen J, Chiu M, et al. Effectiveness and safety of drug-eluting stents in Ontario. The New England Journal of Medicine, 2007, 357: 1393-1402.
|
13. |
Stettler C, Allemann S, wandel S, et al. Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis. British Medical Journal, 2008, 337: al331.
|
14. |
Serruys PW, Ong ATL, van Herwerden LA, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. Joumal of the Ameriean College of Cardiology, 2005, 46: 575-581.
|
15. |
Rodriguez AE,Baldi J, Pereira CF, et al. Five year follow-up of the argentine randomized trial Of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). Journal of the American College of Cardiology, 2005, 46: 582-588.
|
16. |
Hueb W, Lopes NH, Gersh BJ, et al. Five-year follow-up of the Medieine, Angioplasty, or Surgery Study (MASSII): a randomized controlled clinieal trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation, 2007, 115: 1082-1089.
|
17. |
Sabate M, Jimenez-Quevedo P, Angiolillo DJ, et al. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIBETES) trial. Circulation, 2005, 112: 2175-2183.
|
18. |
Holmes DR, Leon MB, Moses JW, et al. Analysis of l-year clinical outcomes in the SIRIUS trial: a randomized trial of sirolimuseluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation, 2004, 109: 634-640.
|
19. |
Hermiller JB, Raizner A, Cannon L, et al. Outeomes with the Polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: The TAXUS-IV trial. J Am Coll Cardiol, 2005, 45: 1172-1179.
|
20. |
Mclellan CS, Ghali WA, Labinaz M, et al. Association between completeness of percutaneous coronary revascularization and postprocedure outcomes. Am Heart J, 2005, 150: 800-806.
|